ArticleMenopause (New York, N.Y.)2026
Menopause experience among people with criminal legal system involvement.
Article in Menopause (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveWe aim to describe menopause symptom burden during and after incarceration for the growing population of women with a history of criminal legal system (CLS) involvement.
methodsWe used Menopause Rating Scale symptom data from the final year of a multiwave cohort of adult women with a history of CLS involvement in three US cities. We also used qualitative semistructured interview data about menopause treatment in the community from adult women from five US states who experienced menopause during their CLS involvement. Descriptive statistics and qualitative thematic analysis were used to triangulate findings.
resultsOf 507 women, 348 (68.8%) reported menstrual cycle data. The mean age was 46. Women were either premenopausal (n=151), early perimenopausal (n=25), late perimenopausal (n=10), or postmenopausal (n=162). Symptoms were common and differed by group. The most severe symptoms in premenopause, early perimenopause, late perimenopause, and postmenopause were joint pain (2.27, SD 1.12), sleep problems (2.44, SD 1.13), joint pain (2.80, SD 0.45), and hot flashes (2.42, SD 1.07), respectively. The qualitative analysis included 29 semistructured interviews focused on access to menopause treatment in the community during or after CLS involvement. Primary themes were logistical barriers (lack of provider, insurance/financial, transportation) and quality of care barriers (poor provider communication skills, lack of provider knowledge).
conclusionWomen with a history of CLS involvement commonly experience menopausal symptoms, some of which are severe. These symptoms are experienced in the context of CLS involvement that may amplify barriers to accessing care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.